- NLNK has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $43.3 million.
- NLNK has traded 70,560 shares today.
- NLNK is up 3.1% today.
- NLNK was down 29.9% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in NLNK with the Ticky from Trade-Ideas. See the FREE profile for NLNK NOW at Trade-Ideas More details on NLNK: NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products to enhance treatment options for patients with cancer. NLNK has a PE ratio of 16. Currently there are 3 analysts that rate NewLink Genetics a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for NewLink Genetics has been 585,800 shares per day over the past 30 days. NewLink has a market cap of $1.5 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.54 and a short float of 24.2% with 4.05 days to cover. Shares are up 30% year-to-date as of the close of trading on Monday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.